Test ID MONOS Infectious Mononucleosis, Rapid Test, Serum
Reporting Name
Infectious Mono Test, SUseful For
Rapid confirmation of a diagnosis of infectious mononucleosis
Specimen Type
SerumSpecimen Required
Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Specimen Volume: 0.5 mL
Specimen Minimum Volume
0.1 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 14 days | |
Frozen | 14 days |
Reference Values
Negative
Reference values apply to all ages.
Day(s) and Time(s) Performed
Monday through Friday; 12 p.m. and 8 p.m.
Saturday, Sunday; 12 p.m.
Test Classification
This test has been cleared, approved or is exempt by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
86308
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
MONOS | Infectious Mono Test, S | 5213-4 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
MONOS | Infectious Mono Test, S | 5213-4 |
Clinical Information
Infectious mononucleosis (IM) is a viral illness that involves reticuloendothelial tissue and is generally limited to children and young adults. IM is most commonly caused by Epstein-Barr virus (EBV). The disease is characterized by fever, sore throat, lymphadenopathy, headache, and fatigue and, on a symptomatic basis, may be confused with other diseases.
Detectable levels of unique heterophile antibodies are produced in patients with IM.
Interpretation
Detectable levels of the infectious mononucleosis (IM) heterophile antibody can usually be expected to occur between the sixth and tenth day following the onset of symptoms. The level usually increases through the second or third week of illness and, thereafter, can be expected to persist, gradually declining over a 12-month period.
Clinical Reference
1. Davidsohn I, Walker PH: The nature of heterophilic antibodies in infectious mononucleosis. Am J Clin Pathol. 1935;5:445-465
2. Peter J, Ray CG: Infectious mononucleosis. Pediatr Rev. 1998;19(8):276-279
3. Johannsen EC, Kaye KM: Epstein-Barr virus (infectious mononucleosis, Epstein-Barr virus-associated malignant diseases, and other diseases). In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Elsevier; 2020:1872-1890
Analytic Time
Same day/1 dayMethod Name
Agglutination
Forms
If not ordering electronically, complete, print, and send a Microbiology Test Request (T244) with the specimen.